CompletedPhase 1

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

United States31 participantsStarted 2022-10-27

Plain-language summary

The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.

Who can participate

Age range21 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cheek pore size assessed as "large" by the investigator * Oily skin on the forehead Exclusion Criteria: * Treatment with Botulinum toxin (BoNT) of any serotype in the face within the last 12 months * Facial cosmetic procedure (e.g., chemical peel, photo rejuvenation, mesotherapy, photodynamic therapy, laser treatment, ultrasound treatment, tattooing of eyebrows) within the last 12 months * Treatment with any dermal filler in the face within the last 12 months * Any previous insertion of permanent material in the face, including permanent dermal fillers (e.g., silicone, polymethyl methacrylate) * Any medical condition that may put the subject at increased risk with exposure to botulinum toxin of any serotype

What they're measuring

Change from Baseline to Week 4 in Pore Volume in the Cheek Area

Timeframe: Baseline (Day 1), Week 4

Change from Baseline to Week 4 in Sebum Level in the Forehead Area

Timeframe: Baseline (Day 1), Week 4

Trial details

NCT IDNCT05784363

SponsorMerz North America, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-06-17

View on ClinicalTrials.gov More Enlarged Pores trials